Intratympanic infliximab is a safe and effective rescue therapy for refractory immune-mediated hearing loss

2019 
Purpose To determine the efficacy and safety of the intratympanic infiltration of infliximab at the hearing threshold of patients in follow-up for refractory immune-mediated hearing loss.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    36
    References
    2
    Citations
    NaN
    KQI
    []